Traynor Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$823K Buy
3,240
+188
+6% +$43.8K 0.04% 150
2026
Q1
$740K Sell
3,052
-158
-5% -$36.8K 0.04% 141
2025
Q4
$664K Buy
3,210
+292
+10% +$57.7K 0.04% 159
2025
Q3
$541K Sell
2,918
-48
-2% -$8.22K 0.03% 176
2025
Q2
$462K Sell
2,966
-348
-11% -$53.5K 0.03% 144
2025
Q1
$550K Sell
3,314
-305
-8% -$47.7K 0.05% 122
2024
Q4
$523K Sell
3,619
-823
-19% -$128K 0.04% 143
2024
Q3
$720K Sell
4,442
-219
-5% -$34.9K 0.04% 122
2024
Q2
$681K Sell
4,661
-6,391
-58% -$950K 0.05% 112
2024
Q1
$1.75M Sell
11,052
-1,004
-8% -$160K 0.15% 75
2023
Q4
$1.89M Sell
12,056
-263
-2% -$40.3K 0.19% 66
2023
Q3
$1.92M Sell
12,319
-767
-6% -$127K 0.24% 64
2023
Q2
$2.17M Sell
13,086
-3,435
-21% -$554K 0.27% 59
2023
Q1
$2.56M Sell
16,521
-4,091
-20% -$661K 0.37% 48
2022
Q4
$3.64M Sell
20,612
-6,350
-24% -$1.1M 0.51% 40
2022
Q3
$4.4M Sell
26,962
-536
-2% -$90.7K 0.79% 28
2022
Q2
$4.88M Sell
27,498
-2,932
-10% -$522K 0.85% 29
2022
Q1
$5.39M Sell
30,430
-892
-3% -$152K 0.7% 34
2021
Q4
$5.36M Sell
31,322
-816
-3% -$134K 0.63% 40
2021
Q3
$5.19M Buy
32,138
+905
+3% +$154K 0.71% 34
2021
Q2
$5.28M Buy
31,233
+1,426
+5% +$236K 0.74% 34
2021
Q1
$4.9M Buy
29,807
+3,493
+13% +$565K 0.81% 33
2020
Q4
$4.14M Sell
26,314
-300
-1% -$44.3K 0.73% 33
2020
Q3
$3.87M Buy
26,614
+1,296
+5% +$192K 0.88% 24
2020
Q2
$3.56M Buy
25,318
+5,157
+26% +$752K 0.86% 25
2020
Q1
$2.64M Buy
20,161
+398
+2% +$56.5K 0.94% 25
2019
Q4
$2.88M Buy
19,763
+960
+5% +$130K 0.77% 35
2019
Q3
$2.43M Buy
18,803
+1,048
+6% +$138K 0.76% 35
2019
Q2
$2.47M Sell
17,755
-1,896
-10% -$262K 0.8% 28
2019
Q1
$2.75M Buy
19,651
+1,145
+6% +$153K 0.92% 24
2018
Q4
$2.39M Buy
18,506
+1,300
+8% +$181K 1% 25
2018
Q3
$2.38M Buy
17,206
+389
+2% +$51.7K 0.77% 26
2018
Q2
$2.04M Buy
16,817
+1,887
+13% +$235K 0.75% 29
2018
Q1
$1.91M Buy
14,930
+2,053
+16% +$277K 0.78% 29
2017
Q4
$1.8M Buy
12,877
+2,055
+19% +$286K 0.77% 30
2017
Q3
$1.4M Buy
10,822
+368
+4% +$48.8K 0.67% 34
2017
Q2
$1.37M Buy
10,454
+1,015
+11% +$129K 0.68% 33
2017
Q1
$1.17M Buy
9,439
+2,231
+31% +$267K 0.65% 30
2016
Q4
$815K Buy
7,208
+553
+8% +$63.9K 0.54% 41
2016
Q3
$762K Buy
6,655
+778
+13% +$94.4K 0.54% 43
2016
Q2
$718K Buy
5,877
+454
+8% +$51.6K 0.56% 41
2016
Q1
$586K Sell
5,423
-911
-14% -$94.3K 0.47% 49
2015
Q4
$650K Buy
6,334
+1,758
+38% +$177K 0.47% 50
2015
Q3
$427K Buy
4,576
+322
+8% +$31.1K 0.37% 58
2015
Q2
$414K Buy
4,254
+1,463
+52% +$147K 0.35% 62
2015
Q1
$280K Buy
2,791
+231
+9% +$23.5K 0.27% 84
2014
Q4
$267K Buy
+2,560
New +$270K 0.31% 78

Other funds holding JNJ

Traynor Capital Management's JNJ Position: Q2 2026 in Review

Traynor Capital Management increased its Johnson & Johnson (JNJ) stake by 6.2% in Q2 2026, buying an estimated $43.8K and bringing the position to 3,240 shares worth $823K. The position accounts for 0.04% of the portfolio, ranked #150.

Traynor Capital Management first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.39M in Q1 2022. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Traynor Capital Management held 3,240 shares of Johnson & Johnson worth $823K as of Q2 2026.
  • Traynor Capital Management bought 188 Johnson & Johnson shares in Q2 2026, an estimated $43.8K.
  • Johnson & Johnson made up 0.04% of Traynor Capital Management's portfolio in Q2 2026, its #150 holding.
  • Traynor Capital Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Traynor Capital Management's Johnson & Johnson position peaked at $5.39M in Q1 2022.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.